R
Ruth Prosser
Researcher at Flinders Medical Centre
Publications - 20
Citations - 585
Ruth Prosser is an academic researcher from Flinders Medical Centre. The author has contributed to research in topics: Inflammatory bowel disease & Crohn's disease. The author has an hindex of 8, co-authored 19 publications receiving 500 citations. Previous affiliations of Ruth Prosser include Flinders University & Royal Adelaide Hospital.
Papers
More filters
Journal ArticleDOI
Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions.
TL;DR: Whether IBD patients' perceptions of the issues surrounding IBD, pregnancy, and childbearing influence their reproductive behavior is determined and specific patient concerns included IBD heritability, the risk of congenital abnormalities, and medication teratogenicity.
Journal ArticleDOI
Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: Patient perceptions
Kate Muller,Ruth Prosser,Peter A. Bampton,Peter A. Bampton,Réme Mountifield,Réme Mountifield,Jane M. Andrews,Jane M. Andrews,Jane M. Andrews +8 more
TL;DR: A large proportion of patients perceive IBD to negatively affect many aspects of sexuality, and female gender negatively affected body image, libido, and sexual activity, while limited resection surgery negatively affects body image.
Journal ArticleDOI
Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.
Réme Mountifield,Réme Mountifield,Réme Mountifield,Ruth Prosser,Peter A. Bampton,Peter A. Bampton,Kate Muller,Jane M. Andrews,Jane M. Andrews,Jane M. Andrews +9 more
TL;DR: This large retrospective study sought patient who reported pregnancy outcomes and examined the relationship between major adverse outcomes, IBD activity and treatment, and subjective data regarding patients' perceptions about IBD management and pregnancy.
Journal ArticleDOI
Crohn's disease and smoking: Is it ever too late to quit?
Ian C. Lawrance,Ian C. Lawrance,Kevin Murray,Birol Batman,Richard B. Gearry,Rachel Grafton,Krupa Krishnaprasad,Jane M. Andrews,Ruth Prosser,Peter A. Bampton,Sharon E. Cooke,Gillian Mahy,Graham L. Radford-Smith,Graham L. Radford-Smith,Graham L. Radford-Smith,Anthony Croft,Katherine Hanigan +16 more
TL;DR: Progression to B2/B3 disease and surgery is reduced by smoking cessation and all CD patients regardless of when they were diagnosed, or how many surgeries, should be strongly encouraged to cease smoking.
Journal ArticleDOI
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study
James D. Doecke,Felicity Hartnell,P. Bampton,Sally Bell,Gillian Mahy,Zubin Grover,Peter Lewindon,Lee W. Jones,Karen Sewell,Krupa Krishnaprasad,Ruth Prosser,D. Marr,Jesse Fischer,Gareth R. Thomas,Jane V. Tehan,Nik S. Ding,Sharon E. Cooke,K. Moss,Alexandra Sechi,P. De Cruz,Rachel Grafton,Susan J. Connor,I.C. Lawrance,Richard B. Gearry,Jane M. Andrews,Graham L. Radford-Smith +25 more
TL;DR: Maintenance anti‐tumour necrosis factor‐α (anti‐TNFα) treatment for Crohn's disease is the standard of care for patients with an inadequate response to corticosteroids and immunomodulators.